Blossom Genetics, **founded** in 2018, is a UK-based startup specializing in **Biotechnology** and **Health Care**. Positioned as a leading player in pharmaceutical contract manufacturing, the company's focus lies in the production and logistics of **medical cannabis products**. Their comprehensive range of services underscores their expertise in this field. Moreover, Blossom Genetics recently secured a Series A investment on **01 April 2022**. Notably, details about the investing party are not disclosed at this time. With a clear focus and a recent injection of capital, Blossom Genetics is poised to make significant strides in the medical cannabis industry.
No recent news or press coverage available for Blossom Genetics.